A Closer Look At Canada's Prescription Drug Policy
This paper discusses Canada's success in restraining drug prices, however, has not fully restrained the growth of prescription drug spending. One reason that drug prices tend to be lower in Canada is that prices for drugs that are still under patent—and therefore have no generic substitutes—are regulated by the federal Patented Medicine Prices Review Board (PMPRB). This Board establishes the maximum prices that can be charged in Canada for patented drugs. The PMPRB has been credited with keeping average annual price increases for patented drugs at or below zero since 1992.
This paper also compares drug policies between Canada and the United States.
Pages: 12
Bibliography: 12 source(s) listed
Filename: 23064 Canada's Prescription Drug Policy.doc
